TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Takeda Pharma A/S
Closing information (x1000 DKK)
| Closing information | 2025/03 | 2024/03 | 2023/03 |
| Turnover |
1,102,419
|
1,118,710
|
1,061,206 |
| Earnings before taxes |
17,145
|
335,727
|
20,852 |
| Total assets |
581,334
|
582,370
|
485,750 |
| Current assets |
563,079
|
547,013
|
410,236 |
| Current liabilities |
203,680
|
215,718
|
375,272 |
| Equity capital |
368,294
|
355,951
|
94,892 |
| - share capital |
10,100
|
10,100
|
10,100 |
| Employees (average) |
350
|
350
|
350 |
Financial ratios
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Solvency |
63.4%
|
61.1%
|
19.5% |
| Turnover per employee |
3,150
|
3,196
|
3,032 |
| Profit as a percentage of turnover |
1.6%
|
30.0%
|
2.0% |
| Return on assets (ROA) | |||
| Current ratio |
276.5%
|
253.6%
|
109.3% |
| Return on equity (ROE) |
4.7%
|
94.3%
|
22.0% |
| Change turnover |
-16,291
|
57,504
|
151,148 |
| Change turnover % |
-1%
|
5%
|
17% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.